383 related articles for article (PubMed ID: 24400095)
21. Functional mesenchymal stem cells remain present in bone marrow microenvironment of patients with leukemia post-allogeneic hematopoietic stem cell transplant.
Ding L; Zhu H; Yang Y; Wang ZD; Zheng XL; Yan HM; Dong L; Zhang HH; Han DM; Xue M; Liu J; Zhu L; Guo ZK; Wang HX
Leuk Lymphoma; 2014 Jul; 55(7):1635-44. PubMed ID: 24180332
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity.
Entrena A; Varas A; Vázquez M; Melen GJ; Fernández-Sevilla LM; García-Castro J; Ramírez M; Zapata AG; Vicente Á
Cancer Lett; 2015 Jul; 363(2):156-65. PubMed ID: 25917077
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia.
Rodríguez-Pardo VM; Aristizabal JA; Jaimes D; Quijano SM; de los Reyes I; Herrera MV; Solano J; Vernot JP
Hematol Oncol Stem Cell Ther; 2013; 6(3-4):89-100. PubMed ID: 24161606
[TBL] [Abstract][Full Text] [Related]
24. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.
Matsuoka Y; Nakatsuka R; Sumide K; Kawamura H; Takahashi M; Fujioka T; Uemura Y; Asano H; Sasaki Y; Inoue M; Ogawa H; Takahashi T; Hino M; Sonoda Y
Stem Cells; 2015 May; 33(5):1554-65. PubMed ID: 25537923
[TBL] [Abstract][Full Text] [Related]
25. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
[TBL] [Abstract][Full Text] [Related]
26. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
27. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
Diaz de la Guardia R; Lopez-Millan B; Lavoie JR; Bueno C; Castaño J; Gómez-Casares M; Vives S; Palomo L; Juan M; Delgado J; Blanco ML; Nomdedeu J; Chaparro A; Fuster JL; Anguita E; Rosu-Myles M; Menéndez P
Stem Cell Reports; 2017 Jun; 8(6):1573-1586. PubMed ID: 28528702
[TBL] [Abstract][Full Text] [Related]
28. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
[TBL] [Abstract][Full Text] [Related]
29. Leukemia-Induced Cellular Senescence and Stemness Alterations in Mesenchymal Stem Cells Are Reversible upon Withdrawal of B-Cell Acute Lymphoblastic Leukemia Cells.
Vanegas NP; Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360930
[TBL] [Abstract][Full Text] [Related]
30. Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.
García-García A; Klein T; Born G; Hilpert M; Scherberich A; Lengerke C; Skoda RC; Bourgine PE; Martin I
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34580200
[TBL] [Abstract][Full Text] [Related]
31. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
Wang X; Cheng Q; Li L; Wang J; Xia L; Xu X; Sun Z
Exp Cell Res; 2012 Feb; 318(3):196-206. PubMed ID: 22100911
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity.
Crippa S; Rossella V; Aprile A; Silvestri L; Rivis S; Scaramuzza S; Pirroni S; Avanzini MA; Basso-Ricci L; Hernandez RJ; Zecca M; Marktel S; Ciceri F; Aiuti A; Ferrari G; Bernardo ME
J Clin Invest; 2019 Feb; 129(4):1566-1580. PubMed ID: 30830876
[TBL] [Abstract][Full Text] [Related]
35. CRTAM
Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
[TBL] [Abstract][Full Text] [Related]
36. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration.
Sassoli C; Vallone L; Tani A; Chellini F; Nosi D; Zecchi-Orlandini S
Cell Tissue Res; 2018 Jun; 372(3):549-570. PubMed ID: 29404727
[TBL] [Abstract][Full Text] [Related]
37. TGFBI Expressed by Bone Marrow Niche Cells and Hematopoietic Stem and Progenitor Cells Regulates Hematopoiesis.
Klamer SE; Dorland YL; Kleijer M; Geerts D; Lento WE; van der Schoot CE; von Lindern M; Voermans C
Stem Cells Dev; 2018 Nov; 27(21):1494-1506. PubMed ID: 30084753
[TBL] [Abstract][Full Text] [Related]
38. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
[TBL] [Abstract][Full Text] [Related]
39. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
[TBL] [Abstract][Full Text] [Related]
40. Comparison of cord blood CD34 + stem cell expansion in coculture with mesenchymal stem cells overexpressing SDF-1 and soluble /membrane isoforms of SCF.
Ajami M; Soleimani M; Abroun S; Atashi A
J Cell Biochem; 2019 Sep; 120(9):15297-15309. PubMed ID: 31099108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
